Loading…
Loading…
SYK · NYSE · Healthcare
“At forty times earnings, Stryker's valuation offers little margin of safety despite its medical device franchise, demanding exceptional growth to justify current prices.”
— In the voice of Graham
Year-to-date total return including price appreciation. Compare performance against the S&P 500 benchmark.
Market Cap
$132.25B
P/E Ratio
40.74
Forward P/E
—
EPS
$8.49
PEG Ratio
0.75
Book Value
$58.66
Dividend Yield
0.97%
Profit Margin
12.92%
ROE
14.48%
Use the interactive ytd return with pre-loaded data for Stryker Corp. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for SYK: